## Core Concept
The question pertains to the registration of B Hepatitis Immune Globulin (BHS/BHIG or HBIG) which is crucial in the prevention of Hepatitis B virus (HBV) infection, particularly in cases of exposure or in newborns of HBV-positive mothers. HBIG contains antibodies against the hepatitis B surface antigen (anti-HBs) and provides immediate, short-term protection against HBV.

## Why the Correct Answer is Right
The correct timing for the administration of HBIG is critical for its effectiveness. For newborns of hepatitis B-positive mothers, the American Academy of Pediatrics and other guidelines recommend that HBIG be given within 12 hours of life, alongside the first dose of hepatitis B vaccine. This approach has been shown to effectively prevent perinatal transmission of HBV.

## Why Each Wrong Option is Incorrect
- **Option A:** This option suggests a delay that could compromise the effectiveness of HBIG in preventing HBV infection in newborns.
- **Option B:** Similarly, this option also suggests a timing that might not be optimal for the immediate protection needed against HBV.
- **Option D:** This option might suggest too early or an impractical timing for routine administration.

## Clinical Pearl / High-Yield Fact
A crucial point to remember is that HBIG is used for post-exposure prophylaxis and provides immediate protection against HBV. It is often administered alongside the hepatitis B vaccine but is not a substitute for vaccination. The timing and use of HBIG can be critical in specific scenarios, such as needlestick injuries or newborns of HBV-positive mothers.

## Correct Answer Line
**Correct Answer: C.**